Dissolution Profile of Mefenamic Acid Solid Dosage Forms in Two Compendial and Biorelevant (FaSSIF) Media

Wilda Nurhikmah1, Yeyet Cahyati Sumirtapura1, Jessie Sofia Pamudji1

  • 1School of Pharmacy Bandung Institute of Technology, Ganesha 10, 40132, Bandung, Indonesia.

Scientia Pharmaceutica
|April 26, 2016
PubMed

Insights

Mefenamic acid dissolution testing revealed significant differences between compendial and biorelevant media. While USP and PPRC methods showed high drug release, biorelevant fasted simulated small intestinal fluid (FaSSIF) demonstrated limited mefenamic acid solubility and dissolution.

Area of Science:

  • Pharmaceutical Sciences
  • Drug Delivery and Formulation
  • Analytical Chemistry

Background:

  • Mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), is classified as a Biopharmaceutical Classification System (BCS) class II drug, characterized by low water solubility and high permeability.
  • Existing compendial methods for dissolution testing, such as those from the United States Pharmacopeia (USP) and the Pharmacopoeia of the People's Republic of China (PPRC), are used for mefenamic acid solid dosage forms.
  • There is growing interest in utilizing 'biorelevant' media to develop more physiologically relevant dissolution test methods.

Purpose of the Study:

  • To investigate the dissolution profiles of mefenamic acid from solid dosage forms (caplets and capsules) available in the Indonesian market.
  • To compare the dissolution performance of mefenamic acid in three different media: USP, PPRC, and biorelevant fasted simulated small intestinal fluid (FaSSIF).
  • To assess the impact of different dissolution media on the solubility and release rate of mefenamic acid.

Main Methods:

  • Dissolution tests were conducted on mefenamic acid caplets and capsules using USP, PPRC, and FaSSIF media.
  • Standard dissolution apparatus (Apparatus II - paddle, or Apparatus I - basket) was employed at 37°C with specified rotation speeds.
  • Solubility of mefenamic acid was determined in each of the three dissolution media at 37°C.

Main Results:

  • Mefenamic acid exhibited the highest solubility in USP medium (~2 mg/mL), followed by PPRC medium (~0.5 mg/mL), and FaSSIF medium (~0.06 mg/mL).
  • Dissolution in USP and PPRC media generally exceeded 75% drug release within 45 minutes for most products, with one exception (PN caplet in USP medium).
  • In contrast, dissolution in the biorelevant FaSSIF medium was significantly lower, with less than 16% of the drug dissolved for all products within the tested timeframe. Capsule dosage forms consistently showed higher dissolution rates across all media.

Conclusions:

  • The choice of dissolution medium significantly impacts the observed dissolution profile of mefenamic acid.
  • Compendial media (USP, PPRC) may overestimate drug release compared to biorelevant FaSSIF, potentially leading to different conclusions about product performance.
  • Biorelevant media like FaSSIF provide a more discriminating assessment of mefenamic acid dissolution, which is crucial given its low solubility (BCS Class II).

Related Concept Videos

Drug Dissolution: Requirements and Profile Comparison01:14

Drug Dissolution: Requirements and Profile Comparison

The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
394
In Vitro Drug Dissolution: Compendial Testing Models I01:13

In Vitro Drug Dissolution: Compendial Testing Models I

Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
458
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
826
Factors Influencing Drug Absorption: Drug Dissolution01:27

Factors Influencing Drug Absorption: Drug Dissolution

The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
1.5K
Modified-Release Drug Delivery Systems: Bioavailability01:30

Modified-Release Drug Delivery Systems: Bioavailability

Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
104
In Vitro Drug Dissolution: Alternative Methods01:17

In Vitro Drug Dissolution: Alternative Methods

Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
334